Home » Topics » Conferences

Conferences
RSS

Cytoskeleton employs novel HTS assay to identify new tubulin ligands

Aug. 26, 1999

Meiji Seika also shows interest in study of integrin receptor antagonists

Aug. 26, 1999

NMI-377, an NO-donating diclofenac derivative with decreased GI side effects

Aug. 26, 1999

Advances in the immunotherapy of cocaine abuse at Scripps Research Institute

Aug. 26, 1999

ACS presentation for new factor Xa inhibitor from Rhone-Poulenc Rorer

Aug. 25, 1999

Academic researchers identify MAb as effective treatment for PCP addiction

Aug. 25, 1999

Cardioselective potassium channel blocker advances to phase II trials at HMR

Aug. 25, 1999

Tanabe Seiyaku pursues integrin receptor antagonists, with interesting results

Aug. 25, 1999

MRS-1595: a novel adenosine antagonist selective for the A2B receptor

Aug. 25, 1999

News from ACS: Abbott and Icos describe antiinflammatory ICAM-1 inhibitor

Aug. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...